UnitedHealth Group (NYSE: UNH) might want to change its stock ticker from "UNH" to "UGH." A string of problems has caused UnitedHealth Group's share price to plunge roughly 50% from the peak set ...

One stock analyst sees more than 100% upside for Nebius Group shares. Nebius' revenue growth is strong and accelerating. The artificial intelligence (AI) cloud services provider has a large cash ...

In recent trading, shares of ICL Group Ltd (Symbol: ICL) have crossed above the average analyst 12-month target price of $6.58, changing hands for $6.64/share. When a stock reaches the target an ...

Cava Group (NYSE: CAVA) absolutely crushed estimates in its first quarter, reported last week, but you wouldn't know it from the stock's trajectory through the past couple of days. According to ...

TKO Group Stock Jumps as Analysts Outline Bullish Views on UFC, WWE Parent Boeing Stock Dropped Following News of Air India Crash—These Are the Key Price Levels to Watch ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them.

The Form 4 filing by UnitedHealth Group (NYSE:UNH) shows that the new CEO, Stephen Hemsley, acquired $25 million worth of company shares at an average of $288.57 a piece on Friday, 16th May 2025.

The stock price of UnitedHealth Group (NYSE: UNH) is sinking yet again this morning after reports that the private healthcare company is now under criminal investigation by the Department of ...

Triumph Group's $26/share acquisition offers a 35.7% premium, with shareholders' approval and promising gains. Read why I maintain my hold rating on TGI stock.

UNH Price Action: UnitedHealth Group shares closed the previous trading session down 22%. The stock was down another 5.09% at $431.00 at the time of publication Monday, per Benzinga Pro . Photo ...

T. Rowe Price Group (NASDAQ:TROW – Get Free Report) had its price objective lowered by research analysts at Barclays from $105.00 to $85.00 in a research report issued to clients and investors ...

T. Rowe Price Group (NASDAQ:TROW – Free Report) had its price objective decreased by The Goldman Sachs Group from $89.00 to $80.00 in a research report sent to investors on Monday morning ...